Roundup

Five things for pharma marketers to know: Friday, January 24, 2020

By

Alison Kanski

Publish Date January 24, 2020

Blue Cross insurers invest in generic drug venture; 23andMe lays off 100 staff; Patient advocacy groups don’t always disclose pharma ties, study finds.

Five things for pharma marketers to know: Thursday, January 23, 2020

By

Carrie Gavit

Publish Date January 23, 2020

J&J reports Q4 earnings; Biolumina partners with AFFIRM to end gun violence; 2020 MM&M Awards now open.

Five things for pharma marketers to know: Wednesday, January 22, 2020

By

Alison Kanski

Publish Date January 22, 2020

Supreme Court will not fast-track ACA lawsuit; Amazon trademarks Amazon Pharmacy internationally; Today is the deadline for MM&M Hall of Femme nominations.

Five things for pharma marketers to know: Tuesday, January 21, 2020

By

Carrie Gavit

Publish Date January 21, 2020

MM&M Hall of Femme deadline Jan. 22; Amarin launches heart health education campaign; Infographic: Younger generations and health insurance.

Five things for pharma marketers to know: Friday, January 17, 2020

By

Alison Kanski

Publish Date January 17, 2020

The FDA is using less-stringent methods to get drugs approved faster, study finds; FTC member endorses Medicare drug negotiation; Planned Parenthood launches largest electoral effort.

Five things for pharma marketers to know: Thursday, January 16, 2020

By

Carrie Gavit

Publish Date January 16, 2020

JPM attendees believe digital health lacks clear definition; MM&M Hall of Femme deadline extension; Celgene exec joins Bluebird Bio.

Five things for pharma marketers to know: Wednesday, January 15, 2020

By

Alison Kanski

Publish Date January 15, 2020

Rochester Drug Co-Operative will stop distributing opioids; SmileDirectClub to begin selling aligners to orthodontists; Eli Lilly to sell more insulin at half price.

Five things for pharma marketers to know: Tuesday, January 14, 2020

By

Alison Kanski

Publish Date January 14, 2020

Biogen to buy early-stage Alzheimer’s treatment; Oklahoma sues drug distributors; HHS urges appeals court to reinstate its TV list price disclosure rule.

Five things for pharma marketers to know: Monday, January 13, 2020

By

Alison Kanski

Publish Date January 13, 2020

23andMe makes first deal to develop drugs based on its genetic data; Oklahoma settles another opioid lawsuit; Eli Lilly to acquire Dermira for $1.1 billion.

Five things for pharma marketers to know: Friday, January 10, 2020

By

Alison Kanski

Publish Date January 10, 2020

AbbVie to create subsidiary for Allergan’s aesthetics products; California plans to sell its own generic drugs; BMS and Sanofi sue Hawaii over free speech.

Five things for pharma marketers to know: Thursday, January 9, 2020

By

Carrie Gavit

Publish Date January 9, 2020

Drug stores sue doctors over opioid crisis; Cancer death rate sees biggest drop; Walgreens misses earnings expectation.

Five things for pharma marketers to know: Wednesday, January 8, 2020

By

Alison Kanski

Publish Date January 8, 2020

Sen. Grassley tries to win over Democrats to his drug pricing bill; Study showed no clear link between talc and ovarian cancer; A look at health gadgets at CES.

Five things for pharma marketers to know: Tuesday, January 7, 2019

By

Alison Kanski

Publish Date January 7, 2020

Gwyneth Paltrow’s Goop is coming to Netflix; Juul to undergo $1 billion restructuring; Merck’s Keytruda shows mixed results in lung cancer trial.

Five things for pharma marketers to know: Monday, January 6, 2020

By

Alison Kanski

Publish Date January 6, 2020

FDA may add menthol to banned vape flavors if teens start using it; States appeal ACA case to the Supreme Court; New Mexico sues J&J over baby powder.

Five things for pharma marketers to know: Friday, January 3, 2020

By

Alison Kanski

Publish Date January 3, 2020

FDA bans some flavored vapes; Drugmakers hike prices on hundreds of drugs; Google’s DeepMind beats doctors in diagnosing breast cancer.